However, independently of which mechanism takes place, it was recently shown that reduction or absence of KLF6 abrogates the negative control of breast cancer cell proliferation triggered by Estrogen Receptor alpha through the signaling pathway mediated by c-Src and Akt activation [49]. The gene discussed is AKT1; the disease is breast carcinoma.